Cognitive Remediation Therapy for Cognitive Dysfunction in Patients With Major Depressive Disorder.
- Published in:
- Psychiatric Annals, 2022, v. 52, n. 3, p. 109, doi. 10.3928/00485713-20220221-02
- By:
- Publication type:
- Article
Works matching IS 00485713 AND DT 2022 AND VI 52 AND IP 3
Results: 8
1
2
Does the Presence of Dissociative Symptoms Affect the Response to Venlafaxine Treatment for Major Depression? An Open-Label, Prospective Study.
- Published in:
- Psychiatric Annals, 2022, v. 52, n. 3, p. 119, doi. 10.3928/00485713-20220222-02
- By:
- Publication type:
- Article
3
Evaluating Cognitive Dysfunction of Major Depressive Disorder in Clinical Settings.
- Published in:
- Psychiatric Annals, 2022, v. 52, n. 3, p. 105, doi. 10.3928/00485713-20220222-01
- By:
- Publication type:
- Article
4
Bridging the Gap From a Clinician's Perspective to Patient-Oriented Remission: Focusing on Cognitive Dysfunction in Depression.
- Published in:
- Psychiatric Annals, 2022, v. 52, n. 3, p. 95, doi. 10.3928/00485713-20220221-03
- By:
- Publication type:
- Article
5
Cognitive Dysfunction in Mood Disorder: Similarities and Differences Between Depression Subtypes.
- Published in:
- Psychiatric Annals, 2022, v. 52, n. 3, p. 100, doi. 10.3928/00485713-20220221-01
- By:
- Publication type:
- Article
6
Cognition in Depression.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
7
The Challenge to Define Best Practice in Psychiatry and the Search for Quality Measures.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
8
Neurocognitive Impairment as a Specifier for the Diagnostic and Statistical Manual of Mental Disorders.
- Published in:
- Psychiatric Annals, 2022, v. 52, n. 3, p. 126, doi. 10.3928/00485713-20220124-01
- By:
- Publication type:
- Article